Home
|
Table of Content - Volume 6 Issue 2 - May 2017
Acute fulminant Hepatitis B treated with entecavir
Jayvirsinh Atodariya1, Virendra C Patil2*, Tejas Rane3, Sandeep Patil4
{1Department of Medicine} {2Department of Gastroenterology} Krishna Institute of Medical Sciences (KIMS) Deemed university, Karad, Maharashtra, INDIA. Email: drtejasrane@gmail.com
Abstract Hepatitis B virus (HBV) infection constitutes a serious global health problem. Acute and subacute liver failure is common complications of viral hepatitis in India and HBV is reckoned to be the etiological agent in 42% and 45% of adult cases, respectively. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. We present here a case of 25 year old lady affected by severe acute hepatitis B with progressive worsening of clinical Condition. The patient was treated with Entecavir. We observed rapid clinical and laboratory improvements. Entecavir should be carefully considered for the treatment of severe acute hepatitis B cases. Key Words: Hepatitis B.
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.